News Archives - Page 92 of 1253

ThursdayOct 12, 2023 11:14 am

NetworkNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Reaches Agreement Regarding Reorganization of Three US Subsidiaries

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, has announced a prepackaged reorganization of some of its subsidiaries. Those subsidiaries include RevitaLid Pharmaceutical Corp., RVL Pharmaceuticals Inc. and RVL Pharmacy, LLC. According to the announcement, a change of control transaction agreement was reached with their sole secured lenders, funds managed by Athyrium Capital Management (“Athyrium”) and other key stakeholders. The transaction will be made through through prepackaged bankruptcy cases that have begun in the U.S. Bankruptcy Court…

ThursdayOct 12, 2023 10:55 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Satispay Collaboration Results in Quantum-Hybrid App that Optimizes Customer Rewards Initiatives

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, is working with Satispay, the leading Italian fintech unicorn revolutionizing mobile payments. The two companies have built a quantum-hybrid application designed to optimize customer rewards initiatives. According to the announcement, the quantum-optimized rewards application shows 50% improvement in customer rewards programs for the same amount of budget. The announcement noted that Satispay has plans to transition the quantum-hybrid application into production. Satispay is seeing increased adoption of its services in countries such as Italy and France as users look…

WednesdayOct 11, 2023 1:50 pm

NetworkNewsBreaks – Untraceable’s Flagship Conference Showcases Ever-Rising Possibilities Unlocked by Blockchain Technologies

Untraceable’s flagship event, the Blockchain Futurist Conference, recently took the spotlight at the iconic Rebel Entertainment Complex and Cabana Pool Bar. As the largest Web3 gathering in Canadian history, this year’s conference brought together global thought leaders and industry luminaries to explore the rapidly evolving technological landscape, hidden opportunities and an increasing number of innovative applications. Thousands of attendees (including developers, visionaries, startup entrepreneurs, investors, financial institutions representatives, technology enthusiasts and nearly 200 speakers) joined the conference, a cornerstone of Canada Crypto Week. IBN’s CryptoCurrencyWire served as an official newswire and a key sponsor of the event, and Jonathan Keim,…

WednesdayOct 11, 2023 1:44 pm

NetworkNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced a new member of its board of directors. Avram Miller, cofounder of Intel Capital, will join the board and will also serve in an advisory role, bringing his invaluable experience to contribute to the company's strategy and business development efforts. Miller’s impressive decades-long career includes strategic and responsible roles in both the technology and medical industries. After spending 13 years in the medical science space, he moved to high tech where, in addition to cofounding Intel Capital, he served as the company’s corporate vice president of…

WednesdayOct 11, 2023 1:35 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being enrolled in 46 clinical trial sites across the United States, Italy, France, Spain and Switzerland. According to the announcement, CNS Pharmaceuticals is on track to achieve value-driving milestones before the end of the year, including…

WednesdayOct 11, 2023 12:26 pm

NetworkNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) to Host Feasibility Study Conference Call and Webcast

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it will host a webcast and conference call at 11:00 a.m. Eastern Time on Thursday, Oct. 12, 2023, to discuss the definitive feasibility study for its Crawford Nickel Sulphide Project. Interested parties should visit https://nnw.fm/D6G2B to register for the event and access the webcast and join the call as detailed in the announcement. For those unable to participate, a web-based archive of the conference call will be available for playback at the same Audience URL used to access the live webcast. To view the full press release, visit https://nnw.fm/UkH1V About Canada…

WednesdayOct 11, 2023 11:30 am

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Receives $1.9M Funding Grant from Canadian Government ACT Program

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, will receive a funding grant of up to $1.9 million through the Research and Innovation Stream of the Agriculture Clean Technology (“ACT”) Program, delivered by Agriculture and Agri-Food Canada (“AAFC”). According to the announcement, the grant was awarded to FuelPositive’s Green NH3 Demonstration Phase Project in support of the commercialization of the FP300 Green Ammonia system. The company noted that it will use the ACT Program funding to gather key information required to continue to adapt its technology to the commercial needs…

TuesdayOct 10, 2023 3:52 pm

NetworkNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director

Zevra Therapeutics (NASDAQ GS: ZVRA), a rare-disease therapeutics company, has named Neil F. McFarlane as president and CEO; McFarlane will also serve on the company’s board of directors. The new appointments are effective immediately. According to the announcement, Christal M.M. Mickle, who has been serving as interim CEO and president since June, will continue serving in her role as chief development officer. A former officer and enlisted soldier in the United States Army Reserves, McFarlane has an impressive, results-driven track record as a biopharmaceutical leader with proven ability to accelerate Zevra’s strategy of melding science, data and patient needs to…

TuesdayOct 10, 2023 2:35 pm

NetworkNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Welcomes COO Jarrett Boon to Its Board of Directors

Safety Shot (NASDAQ: SHOT) today announced that Jarrett Boon, who has served as the company’s chief operating officer since August 2023, has been appointed to Safety Shot’s board of directors. Boon is leading the launch and growth of the company’s Safety Shot functional drink business this quarter. Boon was the co-founder and CEO of GBB Drink Lab, which developed Safety Shot, the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. “In the past few months since I’ve joined the company, our outstanding team has teed up the Safety Shot drink for…

TuesdayOct 10, 2023 2:30 pm

NetworkNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial sector, commencing with banking roles at Paribas and Rabobank before holding several director-level positions at Amsterdam exchanges and then Euronext. Hendriks brings more than 35 years of experience in the asset management industry, having held senior roles at some of the most established financial institutions.…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Breaks Categories: News